Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains

Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains

Antibiotic resistance in <i>Streptococcus pneumoniae</i> has increased worldwide, making fluoroquinolones an alternative therapeutic option. Fluoroquinolones inhibit the type II DNA topoisomerases (topoisomerase IV and gyrase). In this study we have evaluated the in vivo activity of seco...

Full description

Bibliographic Details
Main Authors:	Jose Manuel Tirado-Vélez, David Carreño, David Sevillano, Luis Alou, José Yuste, Adela G. de la Campa
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Antibiotics
Subjects:	<i>Streptococcus pneumoniae</i> DNA topoisomerase I inhibitor seconeolitsine resistance invasive pneumococcal disease.
Online Access:	https://www.mdpi.com/2079-6382/10/5/573

Similar Items

Physiologic and Transcriptomic Effects Triggered by Overexpression of Wild Type and Mutant DNA Topoisomerase I in <i>Streptococcus pneumoniae</i>
by: Miriam García-López, et al.
Published: (2023-10-01)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
by: Brita Askeland Winje, et al.
Published: (2021-08-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
by: Nobuhiro Asai, et al.
Published: (2021-11-01)

Age-Dependent Serotype-Associated Case-Fatality Rate in Invasive Pneumococcal Disease in the Autonomous Community of Madrid between 2007 and 2020
by: Sara De Miguel, et al.
Published: (2021-11-01)

Vaccination against <i>Streptococcus pneumoniae</i> in Children Born between 2015 and 2018 in Poland—How Has the Introduction of Free Compulsory Pneumococcal Vaccination Affected Its Uptake?
by: Wojciech Malchrzak, et al.
Published: (2023-10-01)

Antimicrobial Resistance in <i>Streptococcus pneumoniae</i> before and after the Introduction of Pneumococcal Conjugate Vaccines in Brazil: A Systematic Review
by: Patricia Alice Knupp-Pereira, et al.
Published: (2024-01-01)

Pneumococcal Disease Prevention: Are We on the Right Track?
by: Nicola Principi, et al.
Published: (2021-03-01)

Serotype Distribution and Antimicrobial Susceptibility Pattern of <i>Streptococcus pneumoniae</i> in COVID-19 Pandemic Era in Brazil
by: Samanta C. G. Almeida, et al.
Published: (2024-02-01)

Pneumococcal Serogroups Causing the Most of the Invasive Diseases in Kayseri
by: Duygu EŞEL, et al.
Published: (2002-03-01)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
by: Lucía Fernández-Delgado, et al.
Published: (2021-10-01)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015-03-01)

Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines
by: Ninecia R. Scott, et al.
Published: (2021-03-01)

Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts
by: Rotem Lapidot, et al.
Published: (2020-05-01)

The Health Professional’s View on the Inclusion of Age in the Recommendations for Pneumococcal Vaccination: Results of a Cross-Sectional Survey in France
by: Gaëlle Farge, et al.
Published: (2021-12-01)

Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine
by: Hemant S Agarwal, et al.
Published: (2021-06-01)

Invasive Pneumococcal Disease in People Living with HIV: A Retrospective Case—Control Study in Brazil
by: Roxana Flores Mamani, et al.
Published: (2023-06-01)

Prevalence of Pneumococcal Serotypes in Community-Acquired Pneumonia among Older Adults in Italy: A Multicenter Cohort Study
by: Andrea Orsi, et al.
Published: (2022-12-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
by: Ching-Fen Shen, et al.
Published: (2013-09-01)

Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection
by: Franziska Voß, et al.
Published: (2020-06-01)

Pneumococcal perihepatitis due to hematogeneous dissemination
by: Koichiro Okumura, et al.
Published: (2020-01-01)

Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children
by: Leigh M. Howard, et al.
Published: (2023-09-01)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01)

A Profile of Adult Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia Patients According to Pneumococcal Vaccination Status
by: María Morales-Suárez-Varela, et al.
Published: (2023-10-01)

Pneumonia Mortality Trends in Children under 5 Years of Age in the Context of Pneumococcal Conjugate Vaccination in Peru, 2003–2017
by: Carlos A. Sanchez, et al.
Published: (2023-11-01)

Changes in Fluoroquinolone-Resistant Streptococcus pneumonia after 7-Valent Conjugate Vaccination, Spain
by: Adela G. de la Campa, et al.
Published: (2009-06-01)

Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco
by: Idrissa Diawara, et al.
Published: (2015-11-01)

Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary <i>Streptococcus pneumoniae</i> Challenge during Influenza A Infection
by: Sean Roberts, et al.
Published: (2019-10-01)

Long-term trends in invasive pneumococcal disease in Manitoba, Canada
by: Salaheddin M. Mahmud, et al.
Published: (2017-08-01)

Clinical characteristics and antimicrobial resistance of pneumococcal isolates of pediatric invasive pneumococcal disease in China
by: Cai K, et al.
Published: (2018-11-01)

Pneumococcal Meningitis in Children: Evaluation of 46 Cases
by: Ayper SOMER, et al.
Published: (1999-06-01)

Pneumococcal Choline-Binding Proteins Involved in Virulence as Vaccine Candidates
by: Julio Sempere, et al.
Published: (2021-02-01)

Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan
by: Hsiao-Chun Chi, et al.
Published: (2018-06-01)

Eventos adversos após vacinação contra o pneumococo Adverse events after pneumococcal vaccination
by: Maria Rita Donalisio, et al.
Published: (2007-02-01)

Retrospective study of prognostic factors in pediatric invasive pneumococcal disease
by: Nan-Chang Chiu, et al.
Published: (2017-01-01)

Epidemiology of <i>Streptococcus pneumoniae</i> Serotypes in Jordan Amongst Children Younger than the Age of 5: A National Cross-Sectional Study
by: Munir Abu-Helalah, et al.
Published: (2023-08-01)

Epidemiology of invasive and non-invasive pneumococcal infections in hospitalised adult patients in a Lebanese medical centre, 2006–2015
by: Rima Moghnieh, et al.
Published: (2020-12-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

Invasive pneumococcal disease caused by non-vaccine Streptococcus pneumoniae serotype 24B in an immunocompetent child
by: Naotaka Tamai, MD, et al.
Published: (2024-04-01)

Economic aspects of hospital treated pneumococcal pneumonia and the results of Pneumo 23 vaccine use in Serbia
by: Adžić Tatjana, et al.
Published: (2008-01-01)

Adult pneumococcal vaccination – new opportunities
by: ERNEST KUCHAR, et al.
Published: (2023-03-01)